| Clonal replacement of tumor-specific T cells following PD-1 blockade KE Yost, AT Satpathy, DK Wells, Y Qi, C Wang, R Kageyama, ... Nature medicine 25 (8), 1251-1259, 2019 | 1266 | 2019 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... Nature communications 6 (1), 8760, 2015 | 531 | 2015 |
| A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds A Bruna, OM Rueda, W Greenwood, AS Batra, M Callari, RN Batra, ... Cell 167 (1), 260-274. e22, 2016 | 479 | 2016 |
| Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response KL McNamara, JL Caswell-Jin, R Joshi, Z Ma, E Kotler, GR Bean, ... Nature cancer 2 (4), 400-413, 2021 | 73 | 2021 |
| Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing T Baslan, J Kendall, K Volyanskyy, K McNamara, H Cox, S D'Italia, ... elife 9, e51480, 2020 | 71 | 2020 |
| Harnessing tumor evolution to circumvent resistance KL Pogrebniak, C Curtis Trends in Genetics 34 (8), 639-651, 2018 | 67 | 2018 |
| Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy JL Caswell-Jin, K McNamara, JG Reiter, R Sun, Z Hu, Z Ma, J Ding, ... Nature communications 10 (1), 657, 2019 | 61 | 2019 |
| Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07) SA Hurvitz, JL Caswell-Jin, KL McNamara, JJ Zoeller, GR Bean, ... Nature communications 11 (1), 5824, 2020 | 51 | 2020 |
| Violation of the ISNT rule in nonglaucomatous pediatric optic disc cupping AE Pogrebniak, B Wehrung, KL Pogrebniak, RK Shetty, P Crawford Investigative Ophthalmology & Visual Science 51 (2), 890-895, 2010 | 41 | 2010 |
| Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun 6: 8760 M Murtaza, SJ Dawson, K Pogrebniak, OM Rueda, E Provenzano, J Grant, ... | 13 | 2015 |
| Transcriptome and genome evolution during HER2-amplified breast neoplasia P Lu, J Foley, C Zhu, K McNamara, K Sirinukunwattana, S Vennam, ... Breast Cancer Research 23, 1-15, 2021 | 5 | 2021 |
| Molecular modeling of functional domain of ABCA4: Towards understanding the genotype-to-phenotype relationships in Stargardt’s disease Y Sergeev, K Pogrebniak, B Falsini, W Zein, K Goetz, J Huang, C Peeler, ... Investigative Ophthalmology & Visual Science 54 (15), 1325-1325, 2013 | 1 | 2013 |
| Commentary on “Two-Year Outcomes of Prostatic Artery Embolization for Symptomatic Benign Prostatic Hyperplasia: An International, Multicenter, Prospective Study” KL McNamara, AC Picel CardioVascular and Interventional Radiology 47 (11), 1525-1526, 2024 | | 2024 |
| Commentary on “Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia” Xu X … K McNamara, AC Picel CardioVascular and Interventional Radiology 45 (12), 1810-1811, 2022 | | 2022 |
| The diagnostic value of cytology in parotid Warthin's tumors: International multicenter series. L Liew, K McNamara Wiley, 2020 | | 2020 |
| Abstract P4-07-01: Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the … JL Caswell-Jin, KL McNamara, J Dering, HW Chen, R Dichmann, A Perez, ... Cancer research (Chicago, Ill.) 80 (4_Supplement), P4-P4-07-01, 2020 | | 2020 |
| Abstract P4-10-12: Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial … KL McNamara, JL Caswell-Jin, Z Ma, JJ Zoeller, M Kriner, Z Zhou, ... Cancer Research 80 (4_Supplement), P4-10-12-P4-10-12, 2020 | | 2020 |
| Tumor expression and microenvironment in HER2-positive breast cancer before and on HER2-targeted therapy: Analysis of microarray expression data from the TRIO-US B07 trial JL Caswell-Jin, KL McNamara, J Dering, HW Chen, R Dichmann, A Perez, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Characterizing the tumor and immune microenvironment through treatment to predict response to neoadjuvant HER2-targeted therapy using the Digital Spatial Profiler KL McNamara, JL Caswell-Jin, Z Ma, JJ Zoeller, M Kriner, Z Zhou, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Quantifying Tumor Evolutionary Dynamics and Predictors of Response in HER2-Positive Breast Cancer Treated with Targeted Therapy KL McNamara Stanford University, 2020 | | 2020 |
